Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STONE: Tamsulosin for Urolithiasis
NCT00382265Phase 4Completed
- Start
- Jan 2008
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ureterolithiasis comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Proportion of Patients Passing Their Stone Within 28 Days by Self Report. Started Jan 2008; status: completed.
02
Drugs
tamsulosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on NCT00382265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382265.